THE IMPACT OF THE COVID-19 PANDEMIC ON THE FINANCIAL PERFORMANCE OF PHARMACEUTICAL COMPANIES LISTED ON INDONESIA STOCK EXCHANGE

The COVID-19 pandemic was announced by the Indonesian government on March 2nd, 2020 has an impact on almost all aspects of life. To prevent the COVID-19 pandemic from spreading, the government has adopted the LSSR, CARE, and Vaccination policies. This situation has an impact on companies, for pharma...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ediningsih S.I., Satmoko A.
Formato: article
Lenguaje:EN
RU
Publicado: Russian Journal of Agricultural and Socio-Economic Sciences 2021
Materias:
Acceso en línea:https://doaj.org/article/f721592f366d430c9aee8f209bd7d0a1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f721592f366d430c9aee8f209bd7d0a1
record_format dspace
spelling oai:doaj.org-article:f721592f366d430c9aee8f209bd7d0a12021-12-04T07:59:54ZTHE IMPACT OF THE COVID-19 PANDEMIC ON THE FINANCIAL PERFORMANCE OF PHARMACEUTICAL COMPANIES LISTED ON INDONESIA STOCK EXCHANGE10.18551/rjoas.2021-11.012226-1184https://doaj.org/article/f721592f366d430c9aee8f209bd7d0a12021-11-01T00:00:00Zhttps://doaj.org/toc/2226-1184The COVID-19 pandemic was announced by the Indonesian government on March 2nd, 2020 has an impact on almost all aspects of life. To prevent the COVID-19 pandemic from spreading, the government has adopted the LSSR, CARE, and Vaccination policies. This situation has an impact on companies, for pharmaceutical companies, this is expected to have a positive impact. This study aimed to find out the impact of the COVID-19 pandemic and analyze differences in financial performance as measured by Current Ratio/CR, Debt Ratio/DR, Total Asset Turnover/TATO, Return on Equity/ROE, and Price Earning/PE in pharmaceutical companies listed in Indonesia Stock Exchange 2019-2020. By using a paired sample t-test, the following were found: the financial performance of pharmaceutical companies as measured by CR decreased during the COVID-19 pandemic. Meanwhile, financial performance as measured by DR, TATO, ROE, and PE increased during the COVID-19 pandemic. There was no difference in the financial performance of pharmaceutical companies as measured by CR, DR, TATO, ROE, and PE between before the COVID-19 pandemic and during the COVID-19 pandemic.Ediningsih S.I.Satmoko A.Russian Journal of Agricultural and Socio-Economic Sciencesarticlecurrent ratiodebt ratiototal asset turnoverreturn on equityprice earningAgriculture (General)S1-972ENRURussian Journal of Agricultural and Socio-Economic Sciences, Vol 119, Iss 11, Pp 3-10 (2021)
institution DOAJ
collection DOAJ
language EN
RU
topic current ratio
debt ratio
total asset turnover
return on equity
price earning
Agriculture (General)
S1-972
spellingShingle current ratio
debt ratio
total asset turnover
return on equity
price earning
Agriculture (General)
S1-972
Ediningsih S.I.
Satmoko A.
THE IMPACT OF THE COVID-19 PANDEMIC ON THE FINANCIAL PERFORMANCE OF PHARMACEUTICAL COMPANIES LISTED ON INDONESIA STOCK EXCHANGE
description The COVID-19 pandemic was announced by the Indonesian government on March 2nd, 2020 has an impact on almost all aspects of life. To prevent the COVID-19 pandemic from spreading, the government has adopted the LSSR, CARE, and Vaccination policies. This situation has an impact on companies, for pharmaceutical companies, this is expected to have a positive impact. This study aimed to find out the impact of the COVID-19 pandemic and analyze differences in financial performance as measured by Current Ratio/CR, Debt Ratio/DR, Total Asset Turnover/TATO, Return on Equity/ROE, and Price Earning/PE in pharmaceutical companies listed in Indonesia Stock Exchange 2019-2020. By using a paired sample t-test, the following were found: the financial performance of pharmaceutical companies as measured by CR decreased during the COVID-19 pandemic. Meanwhile, financial performance as measured by DR, TATO, ROE, and PE increased during the COVID-19 pandemic. There was no difference in the financial performance of pharmaceutical companies as measured by CR, DR, TATO, ROE, and PE between before the COVID-19 pandemic and during the COVID-19 pandemic.
format article
author Ediningsih S.I.
Satmoko A.
author_facet Ediningsih S.I.
Satmoko A.
author_sort Ediningsih S.I.
title THE IMPACT OF THE COVID-19 PANDEMIC ON THE FINANCIAL PERFORMANCE OF PHARMACEUTICAL COMPANIES LISTED ON INDONESIA STOCK EXCHANGE
title_short THE IMPACT OF THE COVID-19 PANDEMIC ON THE FINANCIAL PERFORMANCE OF PHARMACEUTICAL COMPANIES LISTED ON INDONESIA STOCK EXCHANGE
title_full THE IMPACT OF THE COVID-19 PANDEMIC ON THE FINANCIAL PERFORMANCE OF PHARMACEUTICAL COMPANIES LISTED ON INDONESIA STOCK EXCHANGE
title_fullStr THE IMPACT OF THE COVID-19 PANDEMIC ON THE FINANCIAL PERFORMANCE OF PHARMACEUTICAL COMPANIES LISTED ON INDONESIA STOCK EXCHANGE
title_full_unstemmed THE IMPACT OF THE COVID-19 PANDEMIC ON THE FINANCIAL PERFORMANCE OF PHARMACEUTICAL COMPANIES LISTED ON INDONESIA STOCK EXCHANGE
title_sort impact of the covid-19 pandemic on the financial performance of pharmaceutical companies listed on indonesia stock exchange
publisher Russian Journal of Agricultural and Socio-Economic Sciences
publishDate 2021
url https://doaj.org/article/f721592f366d430c9aee8f209bd7d0a1
work_keys_str_mv AT ediningsihsi theimpactofthecovid19pandemiconthefinancialperformanceofpharmaceuticalcompanieslistedonindonesiastockexchange
AT satmokoa theimpactofthecovid19pandemiconthefinancialperformanceofpharmaceuticalcompanieslistedonindonesiastockexchange
AT ediningsihsi impactofthecovid19pandemiconthefinancialperformanceofpharmaceuticalcompanieslistedonindonesiastockexchange
AT satmokoa impactofthecovid19pandemiconthefinancialperformanceofpharmaceuticalcompanieslistedonindonesiastockexchange
_version_ 1718372829652582400